Latest On Lonza Group Ltd (LZAGY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-10 23:05 EST | News | Lonza Group AG (LZAGY) Q1 2023 Earnings Call Transcript | N/A |  |
| 2023-05-09 05:57 EST | Dividend | A dividend of $0.19 has been announced on Mar 16, 2023. It will be paid May 26, 2023 with an ex-dividend date of May 9, 2023. | Neutral | |
| 2023-01-26 14:44 EST | News | Lonza: Lower Expectations For 2023 | N/A | |
| 2023-01-26 00:47 EST | News | Lonza Group AG (LZAGY) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-01-25 10:37 EST | News | Lonza Group AG reports FY earnings; confirms FY23 and beyond guidance | N/A | |
| 2023-01-25 10:37 EST | News | Lonza Group AG 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-10-30 20:30 EST | News | Lonza: Positive News From Biogen | N/A | |
| 2022-07-25 21:11 EST | News | Lonza: Growth Is Undervalued | N/A | |
| 2022-07-23 01:32 EST | News | Lonza Group AG (LZAGY) CEO Pierre-Alain Ruffieux on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-07-22 08:24 EST | News | Lonza Group AG Non-GAAP EPS of CHF 7.28, revenue of CHF 2.98B; reaffirms FY22 guidance | N/A | |
| 2022-07-22 08:24 EST | News | Lonza Group AG 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-06-17 04:49 EST | News | Lonza: One Stop Shop For Global Drug Manufacturing, At A Price | N/A | |
| 2022-05-09 05:57 EST | Dividend | A dividend of $0.16 has been announced on Apr 27, 2022. It will be paid May 26, 2022 with an ex-dividend date of May 9, 2022. | Neutral | |
| 2022-03-10 08:39 EST | News | Lonza finishes laboratory expansion at API manufacturing facility in China | N/A | |
| 2022-02-13 04:19 EST | News | Lonza Group: A Net Cash Position But The Strong Growth Ambitions For 2024 Appear To Be Priced In | N/A | |
| 2022-01-28 00:02 EST | News | Lonza to make HaemaLogiX's multiple myeloma drug KappaMab for clinical trials | N/A | |
| 2022-01-26 14:12 EST | News | Lonza Group AG GAAP EPS of CHF39.52, revenue of CHF5.4B | N/A | |
| 2022-01-26 14:12 EST | News | Lonza Group Ltd 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-01-26 14:12 EST | News | Lonza Group AG (LZAGY) CEO Pierre-Alain Ruffieux on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-16 17:04 EST | News | Lonza Group: Moving To A Net Cash Position | N/A | |
| 2021-07-24 04:15 EST | News | Lonza Group Ltd 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-07-24 04:15 EST | News | Lonza Group AG (LZAGY) CEO Pierre-Alain Ruffieux on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-23 11:05 EST | News | Lonza Group AG reports 1H results | N/A | |
| 2021-07-22 12:03 EST | News | Moderna targets 600 million doses of COVID-19 booster shots with new Lonza deal | N/A | |
| 2021-05-10 06:01 EST | Dividend | A dividend of $0.16 has been announced on Apr 21, 2021. It will be paid May 27, 2021 with an ex-dividend date of May 10, 2021. | Neutral | |
| 2021-03-31 12:13 EST | News | Gracell partners with Lonza to manufacture CAR-T cell candidates in U.S. | N/A | |
| 2021-01-29 21:09 EST | Financials | Company financials have been released. | Neutral | |
| 2021-01-29 10:00 EST | News | Lonza Group Ltd (LZAGY) CEO Pierre-Alain Ruffieux on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-01-27 08:10 EST | News | Lonza Group AG reports FY results | N/A | |
| 2021-01-24 19:55 EST | News | Lonza: Riding The Big Pharma Wave | N/A | |
| 2021-01-19 20:47 EST | News | NextPharma to acquire two Lonza sites specialized in Lipid Oral Dosage Forms | N/A | |
| 2020-12-21 00:47 EST | News | Smaller contractors play pivotal role in vaccine supply chain | N/A | |
| 2020-12-02 09:32 EST | News | Moderna amends U.K. pact for 2M more doses of COVID-19 vaccine | N/A | |
| 2020-11-26 22:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-15 04:29 EST | News | Moderna makes headway in bringing COVID vaccine to European market | N/A | |
| 2020-09-26 14:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 06:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 10:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 18:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 14:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:14 EST | Financials | Company financials have been released. | Neutral | |
About Lonza Group Ltd (LZAGY):
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma Biotech & Nutrition, and Specialty Ingredients. The Pharma Biotech & Nutrition segment provides technology platforms, including drug substance and drug product; and develops and manufactures customized active pharmaceutical ingredients and biopharmaceuticals, as well as formulation services and delivery systems for pharmaceutical and nutritional applications. It serves pharmaceutical companies, biotechnology firms, and medical research and testing organizations, as well as consumer health and nutrition companies. The Specialty Ingredients segment operates microbial control solutions and specialty chemical services businesses. Its Microbial control solutions business has offerings in professional hygiene, and home and personal care markets; and offerings in paints and coating, wood protection, material protection, and crop protection. This segments also offers specialty chemicals in electronics, aerospace, food and feed ingredients, agro chemicals, and diversified specialty chemicals markets. The company has collaboration with Moderna, Inc. to manufacture a potential COVID-19 vaccine, mRNA-1273; and an agreement with Capricor Therapeutics, Inc. for the development of CAP-1002, a clinical asset for the treatment of Duchenne Muscular Dystrophy and complications arising from COVID-19. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
General
- Name Lonza Group Ltd
- Symbol LZAGY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 14,000
- Fiscal Year EndDecember
- Web URLhttp://www.lonza.com
View More
Valuation
- Trailing PE 47.66
- Forward PE 41.15
- Price/Sales (Trailing 12 Mt.) 7.57
- Price/Book (Most Recent Quarter) 7.01
- Enterprise Value Revenue 9.06
- Enterprise Value EBITDA 52.15
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 19%
- Return on Assets 4%
- Return on Equity 11%
- Earnings Per Share $1.21
- Revenue Per Share $0
- Gross Profit 1.86 billion
- Quarterly Earnings Growth 3.3%
View More
Highlights
- Market Capitalization 42.61 billion
- PEG Ratio 3.73
- Book Value Per Share $8.62
View More
Share Statistics
- Shares Outstanding 742.54 million
- Shares Float 743.28 million
- % Held by Insiders <1%
- % Held by Institutions 0.87%
View More
Technicals
- Beta 0.45
- 52 Week High $69.07
- 52 Week Low $31.99
- 50 Day Moving Average 63.34
- 200 Day Moving Average 63.15
View More
Dividends
- Forward Annual Dividend Rate $0.14
- Forward Annual Dividend Yield 0.24%
- Payout Ratio 4%
- Dividend Date 2020-05-20
- ExDividend Date 2020-05-01
- Dividend Per Share $2.78
- Dividend Yield 0%
View More
Lonza Group Ltd (LZAGY) Dividend Calendar:
LZAGY's last dividend payment was made to shareholders on May 20, 2020.
Lonza Group Ltd pays out 4% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Lonza Group Ltd (LZAGY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-03-31 | 2020-06-30 | $N/A | $3.37 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $1.52 billion | $3.32 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $1.47 billion | $2.56 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $1.51 billion | $2.49 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $1.49 billion | $2.69 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $N/A | $2.64 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $N/A | $1.81 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $1.55 billion | $1.82 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $1.61 billion | $2.63 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $1.43 billion | $2.72 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $1.16 billion | $1.92 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $1.84 | $0.00 | ||
| 2016-09-30 | 2016-12-31 | $1.00 | $0.00 | ||
| 2016-06-30 | 2016-09-30 | $1.04 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $1.90 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $1.57 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $1.61 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | $1.13 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | $1.09 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $0.94 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.97 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $1.51 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $1.52 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.49 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.49 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.42 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.42 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.94 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.92 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.85 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.90 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.58 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.60 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $1.12 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $1.03 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $1.56 | $0.00 |
Lonza Group Ltd (LZAGY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | N/A | N/A | 210.23 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 337.29 million |
| Gross Profit | N/A | N/A | N/A | N/A | 571.8 million |
| Ebit | N/A | N/A | N/A | N/A | 234.5 million |
| Operating Income | N/A | N/A | N/A | N/A | 234.5 million |
| Income Tax Expense | N/A | N/A | 43 million | 43 million | 19.11 million |
| Total Revenue | N/A | N/A | N/A | N/A | 1.52 billion |
| Cost of Revenue | N/A | N/A | N/A | N/A | 948.86 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -24.28 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 191.12 million |
| Net Income Applicable to Common Shares | N/A | N/A | 238.5 million | 238.5 million | 178.72 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | -235 million | -235 million | -286.16 million | -277.56 million | 136.19 million |
| Net Borrowings | 135.5 million | 135.5 million | -117.77 million | -114.23 million | -127.08 million |
| Total Cash Flow from Financial Activities | N/A | N/A | -87.81 million | -85.17 million | -254.15 million |
| Change to Operating Activities | -191.5 million | -191.5 million | 67.67 million | 65.63 million | -277.44 million |
| Change in Cash | N/A | N/A | 47.52 million | 46.09 million | -34.93 million |
| Total Cash from Operating Activities | 217 million | 217 million | 423.55 million | 410.82 million | 84.04 million |
| Depreciation | N/A | N/A | 36.16 million | 35.07 million | 50.12 million |
| Other Cash Flow from Investing Activities | -6 million | -6 million | 8.78 million | 8.52 million | -21.77 million |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | 42 million | 42 million | 30.48 million | 29.56 million | 506277.85 |
| Change to Net Income | 36 million | 36 million | 141.01 million | 136.77 million | 159.98 million |
| Capital Expenditures | N/A | N/A | 246.9 million | 239.48 million | 155.93 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 7.41 billion | N/A | 7.52 billion |
| Total Stockholder Equity | N/A | N/A | 6.47 billion | N/A | 6.71 billion |
| Other Current Liabilities | 2.31 billion | 2.31 billion | 1.61 billion | N/A | 1.97 billion |
| Total Assets | N/A | N/A | 13.95 billion | N/A | 14.3 billion |
| Common Stock | 74 million | 74 million | 74 million | 74 million | 76.45 million |
| Other Current Assets | 4.3 billion | 4.3 billion | 2.54 billion | N/A | 2.63 billion |
| Retained Earnings | 4.95 billion | 4.95 billion | 3.99 billion | 3.99 billion | 4.01 billion |
| Other Liabilities | 1.69 billion | 1.69 billion | 1.98 billion | 1.98 billion | 1.9 billion |
| Other Assets | 9.64 billion | 9.64 billion | 10.82 billion | 10.82 billion | 11.16 billion |
| Cash | N/A | N/A | 557 million | N/A | 521.69 million |
| Total Current Liabilities | 3.11 billion | 3.11 billion | 1.94 billion | N/A | 2.74 billion |
| Other Stockholder Equity | -948 million | -948 million | -899 million | -899 million | -747.93 million |
| Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | 4.8 billion | 4.8 billion | 3.13 billion | N/A | 3.15 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 6.78 billion | 6.78 billion | 6.47 billion | 6.47 billion | 6.71 billion |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | 2.89 billion |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A |
Lonza Group Ltd (LZAGY) Chart:
Lonza Group Ltd (LZAGY) News:
Below you will find a list of latest news for Lonza Group Ltd (LZAGY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Lonza Group Ltd (LZAGY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Lonza Group Ltd (LZAGY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2008-10-10 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1446711/000101915508000319/0001019155-08-000319-index.htm |
| 2008-10-20 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1446711/000114420408058351/0001144204-08-058351-index.htm |
| 2008-11-06 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1446711/000114420408061469/0001144204-08-061469-index.htm |
| 2008-11-04 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1446711/000119380508002756/0001193805-08-002756-index.htm |
| 2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1446711/000119380517003104/0001193805-17-003104-index.htm |
| 2019-11-25 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1446711/000119380519001787/0001193805-19-001787-index.htm |
| 2014-10-29 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1446711/000157104914005545/0001571049-14-005545-index.htm |